Skip to main navigation Skip to search Skip to main content

Probing the binding affinity of amyloids to reduce toxicity of oligomers in diabetes

  • McGill University
  • CEA-Saclay

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Motivation: Amyloids play a role in the degradation of β-cells in diabetes patients. In particular, short amyloid oligomers inject themselves into the membranes of these cells and create pores that disrupt the strictly controlled flow of ions through the membranes. This leads to cell death. Getting rid of the short oligomers either by a deconstruction process or by elongating them into longer fibrils will reduce this toxicity and allow the β-cells to live longer. Results: We develop a computational method to probe the binding affinity of amyloid structures and produce an amylin analog that binds to oligomers and extends their length. The binding and extension lower toxicity and β-cell death. The amylin analog is designed through a parsimonious selection of mutations and is to be administered with the pramlintide drug, but not to interact with it. The mutations (T9K L12K S28H T30K) produce a stable native structure, strong binding affinity to oligomers, and long fibrils. We present an extended mathematical model for the insulin-glucose relationship and demonstrate how affecting the concentration of oligomers with such analog is strictly coupled with insulin release and β-cell fitness.

Original languageEnglish
Pages (from-to)2294-2302
Number of pages9
JournalBioinformatics
Volume31
Issue number14
DOIs
StatePublished - 15 Jul 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Probing the binding affinity of amyloids to reduce toxicity of oligomers in diabetes'. Together they form a unique fingerprint.

Cite this